Using diabetic mouse model, we demonstrated that treatment with HO-1 agonist, hemin, markedly attenuated the DN-induced renal injury as evidenced by reduced albuminuria, ameliorated glomerulosclerosis and increased nephrin expression. Here, HMOX1 is linked to glomerulosclerosis.